These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33078915)

  • 21. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
    Motawi TM; Atta HM; Sadik NA; Azzam M
    Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study on effect of mesenchymal stem cells and endothelial progenitor cells on treatment of experimental CCL4-induced liver fibrosis.
    Abdelgwad M; Ewaiss M; Sabry D; Khalifa WA; Altaib ZM; Alhelf M
    Arch Physiol Biochem; 2022 Aug; 128(4):1071-1080. PubMed ID: 32374186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility.
    Xin L; Lin X; Pan Y; Zheng X; Shi L; Zhang Y; Ma L; Gao C; Zhang S
    Acta Biomater; 2019 Jul; 92():160-171. PubMed ID: 31075515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel minimally invasive OFM technique with orthotopic transplantation of hUC-MSCs and in vivo monitoring of liver metabolic microenvironment in liver fibrosis treatment.
    Yang H; Xie Y; Li T; Liu S; Zeng S; Wang B
    Stem Cell Res Ther; 2021 Oct; 12(1):534. PubMed ID: 34627378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
    Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
    Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
    Idriss NK; Sayyed HG; Osama A; Sabry D
    Cell Physiol Biochem; 2018; 48(5):2161-2171. PubMed ID: 30114694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of repeated intravenous infusions of umbilical cord-derived versus bone marrow-derived mesenchymal stem cells on angiogenesis in a pregnant experimentally induced deep venous thrombosis rat model.
    Cheng X; Wang W; Du R; Zhang M; Xie Y; Sun W; Ji J; Sun B; Zhang Y
    In Vitro Cell Dev Biol Anim; 2022 Dec; 58(10):957-969. PubMed ID: 36469244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracerebral and Intravenous Transplantation Represents a Favorable Approach for Application of Human Umbilical Cord Mesenchymal Stromal Cells in Intracerebral Hemorrhage Rats.
    Xie J; Wang B; Wang L; Dong F; Bai G; Liu Y
    Med Sci Monit; 2016 Oct; 22():3552-3561. PubMed ID: 27703134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy.
    Zheng X; Zhou X; Ma G; Yu J; Zhang M; Yang C; Hu Y; Ma S; Han Z; Ning W; Jin B; Zhou X; Wang J; Han Y
    Stem Cell Res Ther; 2022 Aug; 13(1):403. PubMed ID: 35932064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
    Xuan J; Feng W; An ZT; Yang J; Xu HB; Li J; Zhao ZF; Wen W
    Mol Cell Biochem; 2017 May; 429(1-2):113-122. PubMed ID: 28181132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats.
    Miyano K; Ikehata M; Ohshima K; Yoshida Y; Nose Y; Yoshihara SI; Oki K; Shiraishi S; Uzu M; Nonaka M; Higami Y; Uezono Y
    PLoS One; 2022; 17(2):e0262892. PubMed ID: 35157707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of mesenchymal stromal cells from peritoneal dialysis effluent with those from umbilical cords: characteristics and therapeutic effects on chronic peritoneal dialysis in uremic rats.
    Du Y; Zong M; Guan Q; Huang Z; Zhou L; Cai J; da Roza G; Wang H; Qi H; Lu Y; Du C
    Stem Cell Res Ther; 2021 Jul; 12(1):398. PubMed ID: 34256856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
    Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
    Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis.
    Kim MD; Kim SS; Cha HY; Jang SH; Chang DY; Kim W; Suh-Kim H; Lee JH
    Exp Mol Med; 2014 Aug; 46(8):e110. PubMed ID: 25145391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Umbilical Cord Mesenchymal Stem Cells Improve Lung Function in Chronic Obstructive Pulmonary Disease Rat Model Through Regulating Lung Microbiota.
    Zhang X; Hu T; Yu X; Wang T; Jiang L; Sun L; Han W
    Stem Cells; 2024 Apr; 42(4):346-359. PubMed ID: 38279981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Promising Effects of Transplanted Umbilical Cord Mesenchymal Stem Cells on the Treatment in Traumatic Brain Injury.
    Qi L; Xue X; Sun J; Wu Q; Wang H; Guo Y; Sun B
    J Craniofac Surg; 2018 Oct; 29(7):1689-1692. PubMed ID: 30234712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis.
    Su DN; Wu SP; Xu SZ
    Stem Cell Res Ther; 2020 Sep; 11(1):395. PubMed ID: 32928296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis.
    Mazhari S; Gitiara A; Baghaei K; Hatami B; Rad RE; Asadirad A; Joharchi K; Tokhanbigli S; Hashemi SM; Łos MJ; Aghdaei HA; Zali MR; Ghavami S
    Eur J Pharmacol; 2020 Sep; 882():173263. PubMed ID: 32535098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.